Eagle Pharmaceuticals, Inc.

Historical 13F Holders

Symbol
EGRX
CUSIP
269796108
All holders as of
Q1 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q1 2 12.4 k $12.1 k
2024 Q4 9 79.0 k $38.7 k
2024 Q3 69 8.56 M $31.9 M
2024 Q2 83 12.2 M $68.2 M
2024 Q1 98 11.3 M $59.0 M
2023 Q4 111 10.6 M $55.3 M
2023 Q3 113 10.3 M $163 M
2023 Q2 131 10.8 M $209 M
2023 Q1 156 11.8 M $334 M
2022 Q4 158 12.5 M $366 M
2022 Q3 161 12.8 M $337 M
2022 Q2 166 11.6 M $517 M
2022 Q1 164 11.3 M $557 M
2021 Q4 167 11.3 M $575 M
2021 Q3 153 11.8 M $660 M
2021 Q2 147 12.0 M $516 M
2021 Q1 157 12.2 M $508 M
2020 Q4 170 12.6 M $588 M
2020 Q3 178 12.8 M $542 M
2020 Q2 168 13.2 M $633 M
2020 Q1 174 13.4 M $617 M
2019 Q4 186 13.5 M $812 M
2019 Q3 193 13.3 M $755 M
2019 Q2 198 13.6 M $758 M
2019 Q1 196 14.5 M $731 M
2018 Q4 192 15.2 M $615 M
2018 Q3 206 15.7 M $1.09 B
2018 Q2 193 15.4 M $1.16 B
2018 Q1 185 15.9 M $836 M
2017 Q4 183 16.0 M $853 M
2017 Q3 188 15.9 M $948 M
2017 Q2 187 19.0 M $1.21 B
2017 Q1 156 16.6 M $1.37 B
2016 Q4 161 16.6 M $1.32 B
2016 Q3 150 17.3 M $1.17 B
2016 Q2 131 17.2 M $667 M
2016 Q1 140 15.9 M $643 M
2015 Q4 146 15.0 M $1.33 B
2015 Q3 129 15.0 M $1.11 B
2015 Q2 124 13.4 M $1.08 B
2015 Q1 68 11.7 M $489 M
2014 Q4 28 9.20 M $143 M
2014 Q3 27 2.97 M $37.6 M
2014 Q2 28 1.74 M $25.0 M
2014 Q1 28 1.91 M $24.4 M